Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Microbiome ; 9(1): 130, 2021 06 05.
Artigo em Inglês | MEDLINE | ID: mdl-34090540

RESUMO

BACKGROUND: Out of the many pathogenic bacterial species that are known, only a fraction are readily identifiable directly from a complex microbial community using standard next generation DNA sequencing. Long-read sequencing offers the potential to identify a wider range of species and to differentiate between strains within a species, but attaining sufficient accuracy in complex metagenomes remains a challenge. METHODS: Here, we describe and analytically validate LoopSeq, a commercially available synthetic long-read (SLR) sequencing technology that generates highly accurate long reads from standard short reads. RESULTS: LoopSeq reads are sufficiently long and accurate to identify microbial genes and species directly from complex samples. LoopSeq perfectly recovered the full diversity of 16S rRNA genes from known strains in a synthetic microbial community. Full-length LoopSeq reads had a per-base error rate of 0.005%, which exceeds the accuracy reported for other long-read sequencing technologies. 18S-ITS and genomic sequencing of fungal and bacterial isolates confirmed that LoopSeq sequencing maintains that accuracy for reads up to 6 kb in length. LoopSeq full-length 16S rRNA reads could accurately classify organisms down to the species level in rinsate from retail meat samples, and could differentiate strains within species identified by the CDC as potential foodborne pathogens. CONCLUSIONS: The order-of-magnitude improvement in length and accuracy over standard Illumina amplicon sequencing achieved with LoopSeq enables accurate species-level and strain identification from complex- to low-biomass microbiome samples. The ability to generate accurate and long microbiome sequencing reads using standard short read sequencers will accelerate the building of quality microbial sequence databases and removes a significant hurdle on the path to precision microbial genomics. Video abstract.


Assuntos
Sequenciamento de Nucleotídeos em Larga Escala , Microbiota , Metagenoma , Microbiota/genética , RNA Ribossômico 16S/genética , Análise de Sequência de DNA
2.
Methods Mol Biol ; 852: 35-47, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22328424

RESUMO

The throughput of DNA reading (i.e., sequencing) has dramatically increased recently owing to the incorporation of in vitro clonal amplification. The throughput of DNA writing (i.e., synthesis) is trailing behind, with cloning and sequencing constituting the main bottleneck. To overcome this bottleneck, an in vitro alternative for in vivo DNA cloning needs to be integrated into DNA synthesis methods. Here, we show how a new single-molecule PCR (smPCR)-based procedure can be employed as a general substitute for in vivo cloning, thereby allowing for the first time in vitro DNA synthesis. We integrated this rapid and high fidelity in vitro procedure into our previously described recursive DNA synthesis and error correction procedure and used it to efficiently construct and error-correct a 1.8-kb DNA molecule from synthetic unpurified oligonucleotides, entirely in vitro. Although we demonstrate incorporating smPCR in a particular method, the approach is general and can be used, in principle, in conjunction with other DNA synthesis methods as well.


Assuntos
DNA/biossíntese , DNA/genética , Reação em Cadeia da Polimerase/métodos , Calibragem , Clonagem Molecular , DNA/isolamento & purificação , DNA/metabolismo , Primers do DNA/genética , DNA de Cadeia Simples/genética , DNA de Cadeia Simples/isolamento & purificação , DNA de Cadeia Simples/metabolismo , Exonucleases/metabolismo , Genes Sintéticos/genética , Oligodesoxirribonucleotídeos/síntese química , Oligodesoxirribonucleotídeos/genética , Fosforilação
3.
Methods Mol Biol ; 852: 151-63, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22328432

RESUMO

Making faultless complex objects from potentially faulty building blocks is a fundamental challenge in computer engineering, nanotechnology, and synthetic biology. We developed an error-correcting recursive construction procedure that attempts to address this challenge. Making DNA molecules from synthetic oligonucleotides using the procedure described here surpasses existing methods for de novo DNA synthesis in speed, precision, and amenability to automation. It provides for the first time a unified DNA construction platform for combining synthetic and natural DNA fragments, for constructing designer DNA libraries, and for making the faultless long synthetic DNA building blocks needed for de novo genome construction.


Assuntos
DNA/biossíntese , DNA/genética , Biblioteca Gênica , Engenharia Genética/métodos , Oligodesoxirribonucleotídeos/metabolismo , Algoritmos , Clonagem Molecular , DNA/isolamento & purificação , DNA/metabolismo , Primers do DNA/genética , DNA de Cadeia Simples/metabolismo , Exodesoxirribonucleases/metabolismo , Fosforilação , Reação em Cadeia da Polimerase , Biologia Sintética/métodos
4.
Methods Enzymol ; 498: 207-45, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21601680

RESUMO

Making error-free, custom DNA assemblies from potentially faulty building blocks is a fundamental challenge in synthetic biology. Here, we show how recursion can be used to address this challenge using a recursive procedure that constructs error-free DNA molecules and their libraries from error-prone synthetic oligonucleotides and naturally existing DNA. Specifically, we describe how divide and conquer (D&C), the quintessential recursive problem-solving technique, is applied in silico to divide target DNA sequences into overlapping, albeit error prone, oligonucleotides, and how recursive construction is applied in vitro to combine them to form error-prone DNA molecules. To correct DNA sequence errors, error-free fragments of these molecules are then identified, extracted, and used as new, typically longer and more accurate, inputs to another iteration of the recursive construction procedure; the entire process repeats until an error-free target molecule is formed. The method allows combining synthetic and natural DNA fragments into error-free designer DNA libraries, thus providing a foundation for the design and construction of complex synthetic DNA assemblies.


Assuntos
DNA/genética , Biblioteca Gênica , Genes Sintéticos , Biologia Sintética/métodos , Algoritmos , Sequência de Bases , Biologia Computacional/métodos , DNA/biossíntese , Eletroforese Capilar/métodos , Engenharia Genética/métodos , Dados de Sequência Molecular , Oligonucleotídeos/genética , Reação em Cadeia da Polimerase/métodos , Proteínas/química , Proteínas/genética
5.
Mol Syst Biol ; 4: 191, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18463615

RESUMO

Making faultless complex objects from potentially faulty building blocks is a fundamental challenge in computer engineering, nanotechnology and synthetic biology. Here, we show for the first time how recursion can be used to address this challenge and demonstrate a recursive procedure that constructs error-free DNA molecules and their libraries from error-prone oligonucleotides. Divide and Conquer (D&C), the quintessential recursive problem-solving technique, is applied in silico to divide the target DNA sequence into overlapping oligonucleotides short enough to be synthesized directly, albeit with errors; error-prone oligonucleotides are recursively combined in vitro, forming error-prone DNA molecules; error-free fragments of these molecules are then identified, extracted and used as new, typically longer and more accurate, inputs to another iteration of the recursive construction procedure; the entire process repeats until an error-free target molecule is formed. Our recursive construction procedure surpasses existing methods for de novo DNA synthesis in speed, precision, amenability to automation, ease of combining synthetic and natural DNA fragments, and ability to construct designer DNA libraries. It thus provides a novel and robust foundation for the design and construction of synthetic biological molecules and organisms.


Assuntos
DNA/metabolismo , Oligonucleotídeos/metabolismo , Biblioteca Gênica , Proteínas de Fluorescência Verde/metabolismo , Proteínas Mutantes/metabolismo , Proteína Supressora de Tumor p53/metabolismo
6.
J Mol Biol ; 360(5): 1019-30, 2006 Jul 28.
Artigo em Inglês | MEDLINE | ID: mdl-16815442

RESUMO

Type I interferons (IFNs) elicit antiviral, antiproliferative and immunomodulatory properties in cells. All of them bind to the same receptor proteins, IFNAR1 and IFNAR2, with different affinities. While the 13 known IFNalphas are highly conserved, the C-terminal unstructured tail was found to have large variation in its net charge, from neutral to +4. This led us to speculate that the tail may have a role in modulation of the IFN biological activity, through fine-tuning the binding to IFNAR2. To evaluate this hypothesis, we replaced the tail of IFNalpha2 with that of IFNalpha8 and IFNbeta tails, or deleted the last five residues of this segment. Mutations to the more positively charged tail of IFNalpha8 resulted in a 20-fold higher affinity to IFNAR2, which results in a higher antiviral and antiproliferative activity. Double and multiple mutant cycle analysis placed the tail near a negatively charged loop on IFNAR2, comprising of residues Glu 132-134. Deleting the tail resulted in only twofold reduction in binding compared to the wild-type. Next, we modeled the location of the tail using a two-step procedure: first we generated 200 models of the tail docked on IFNAR2 using HADDOCK, second the models were scored according to the fit between experimentally determined rates of association of nine mutant complexes, and their calculated rates using the PARE software. From the results we suggest that the unstructured tail of IFNalpha is gaining a specific structure in the bound state, binding to a groove below the 132-134 loop in IFNAR2.


Assuntos
Interferon Tipo I/metabolismo , Proteínas de Membrana/metabolismo , Modelos Moleculares , Receptores de Interferon/metabolismo , Antineoplásicos/farmacologia , Antivirais/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Humanos , Interferon Tipo I/genética , Interferon Tipo I/farmacologia , Mutagênese Sítio-Dirigida , Mutação , Ligação Proteica , Estrutura Terciária de Proteína , Receptor de Interferon alfa e beta , Proteínas Recombinantes , Vírus da Estomatite Vesicular Indiana/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA